Phillip Gomez, Siga Technologies CEO

Siga nabs $10.7M from the US gov­ern­ment in deal for its mon­key­pox an­tivi­ral

The US gov­ern­ment is all set to buy $10.7 mil­lion worth of Siga Tech­nolo­gies’ mon­key­pox oral an­tivi­ral, the com­pa­ny an­nounced Thurs­day.

Of the to­tal dos­es, $5.1 mil­lion worth of oral an­tivi­rals called Tpoxx (tecovir­i­mat) will be de­liv­ered this year, with the US De­part­ment of De­fense hav­ing the op­tion of buy­ing the rest at a lat­er point.

The new con­tract fol­lows an ear­li­er one in which the gov­ern­ment had pur­chased $7.4 mil­lion worth of Tpoxx from the com­pa­ny.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.